Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients.

José Antonio Mata-Marín,Gloria Huerta-García,Juan Carlos Domínguez-Hermosillo,Marcelino Chávez-García,Marco Isaac Banda-Lara,Nohemí Nuñez-Rodríguez,Javier Enrique Cruz-Herrera,Jorge Luis Sandoval-Ramírez,Ivan Martínez-Abarca,Alfredo Villagómez-Ruiz,Bulmaro Manjarrez-Tellez,Jesús Gaytán Martínez

Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients.

2015

José Antonio Mata-Marín
Gloria Huerta-García
Juan Carlos Domínguez-Hermosillo
Marcelino Chávez-García
Marco Isaac Banda-Lara
Nohemí Nuñez-Rodríguez
Javier Enrique Cruz-Herrera
Jorge Luis Sandoval-Ramírez
Ivan Martínez-Abarca
Alfredo Villagómez-Ruiz
Bulmaro Manjarrez-Tellez
Jesús Gaytán Martínez

Objective We evaluated the effectiveness of darunavir (DRV) treatment plus an optimized background regimen in 120 HIV-1 treatment-experienced patients.

Keywords:

Tenofovir
Drug resistance
Darunavir
Raltegravir
Virology
Regimen
Maraviroc
Pharmacology
Medicine
treatment experienced
human immunodeficiency virus
hiv infected patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations